Literature DB >> 24634945

Is BCLC algorithm useful in clinical practice? Study on 164 HCC patients.

Maria Antonietta Trovato, Antonio Pesce, Maria Sofia, Arturo Montineri, Antonio Basile, Filippo Palermo, Filippo Fatuzzo, Luciano Nigro, Stefano Puleo.   

Abstract

BACKGROUND/AIMS: The Barcelona Clinic Liver Cancer (BCLC) classification has been recently validated as the best system for treatment guidance for hepatocellular carcinoma (HCC). The aim of this retrospective study is to evaluate the usefulness of BCLC in the treatment of HCC comparing our treatment decision and the BCLC algorithm indications.
METHODOLOGY: In 102 patients affected by HCC observed from 1991 to 2002 a retrospective analysis was performed. The choice of treatment was compared with the treatment schedule proposed by BCLC. Whereas the second group of 62 patients observed from 2008 to 2010 was analysed both retrospectively in comparison with the BCLC classification.
RESULTS: We found a disagreement in between our decision making and the choices suggested by BCLC. We only found a statistical significance for age and performance status test. In surgical patients the median age and the PST class were lower with a statistically significant p value (0.04 and 0.03, respectively).
CONCLUSIONS: The BCLC system would not have changed our decision either in the past, or in present days, especially in surgical indications. Even if the decision making is affected by BCLC, actually that process still needs the support of the experience of each clinical centre involved.

Entities:  

Mesh:

Year:  2013        PMID: 24634945

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Letter to the Editor: Use of Direct Liver Stiffness Measurement in Evaluating the Severity of Liver Cirrhosis in Patients with Hepatocellular Carcinoma.

Authors:  Antonio Pesce; Carlo Vittorio Feo
Journal:  World J Surg       Date:  2020-10-11       Impact factor: 3.352

2.  A rare case of Krukenberg tumor by gallbladder cancer.

Authors:  Antonio Pesce; Giovanni Li Destri; Francesca Flavia Amore; Gaetano Magro; Gaetano La Greca; Stefano Puleo
Journal:  Ann Med Surg (Lond)       Date:  2019-10-04

3.  Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.

Authors:  Yongjiang Li; Yangxun Pan; Ximeng Lin; Jingyu Hou; Zili Hu; Li Xu; Zhongguo Zhou; Yaojun Zhang; Minshan Chen; Dandan Hu
Journal:  Front Pharmacol       Date:  2022-02-08       Impact factor: 5.810

4.  Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.

Authors:  Eloy Ruiz; Teresa Rojas Rojas; Francisco Berrospi; Ivan Chávez; Carlos Luque; Luis Cano; Franco Doimi; Pascal Pineau; Eric Deharo; Stéphane Bertani
Journal:  Heliyon       Date:  2016-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.